V3 loop of human immunodeficiency virus type 1 reduces cyclin E expression and induces G1 arrest in interleukin 2-dependent T cells

AIDS Res Hum Retroviruses. 1998 Jan 1;14(1):31-8. doi: 10.1089/aid.1998.14.31.

Abstract

We previously described that V3 loop derived from the HTLV-III BH10 clone V3-BH10 markedly suppressed IL-2-driven T cell proliferation and produced G1 arrest of the cells. Here, we tested the effect of V3-BH10 on the molecules that are involved in transition from the G1 to S phase of the cell cycle. The effect of V3-BH10 on the IL-2-induced expression of G1 cyclins, Cdk inhibitors, and phosphorylation of retinoblastoma protein (pRb) was tested by immunoblotting, using the IL-2-dependent CD4-positive cell line Kit 225. Furthermore, IL-2-dependent kinase activity of the cyclin E-Cdk2 complex was investigated with histone H1 as a substrate. V3-BH10 reduced the IL-2-dependent expression of cyclin E, but not that of cyclin D and Cdk inhibitors such as p21 and p27. As the result of reduction of cyclin E, histone H1 kinase activity of the cyclin E-Cdk2 complex was markedly reduced even in the presence of rIL-2, followed by incomplete phosphorylation of pRb. The reduction in hyperphosphorylation of pRb by V3-BH10 led to G1 arrest of the cell cycle. Thus, V3-BH10 induced G1 arrest in IL-2-dependent cell cycle progression by reducing cyclin E expression, which may be one of the mechanisms underlying the dysfunction of T cells in HIV-1-infected people.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blotting, Western
  • CDC2-CDC28 Kinases*
  • Cells, Cultured
  • Cyclin D1 / genetics
  • Cyclin D2
  • Cyclin D3
  • Cyclin E / drug effects
  • Cyclin E / genetics*
  • Cyclin E / metabolism
  • Cyclin-Dependent Kinase 2
  • Cyclin-Dependent Kinases / antagonists & inhibitors
  • Cyclin-Dependent Kinases / metabolism
  • Cyclins / genetics
  • G1 Phase / drug effects*
  • HIV Envelope Protein gp120 / pharmacology*
  • HIV-1 / genetics*
  • Humans
  • Interleukin-2 / pharmacology*
  • Peptide Fragments / pharmacology*
  • Phosphorylation
  • Protein Kinases / drug effects
  • Protein Kinases / metabolism
  • Protein Serine-Threonine Kinases / antagonists & inhibitors
  • Protein Serine-Threonine Kinases / metabolism
  • Recombinant Proteins / pharmacology
  • S Phase / drug effects*
  • T-Lymphocytes / cytology
  • T-Lymphocytes / drug effects*

Substances

  • CCND2 protein, human
  • CCND3 protein, human
  • Cyclin D2
  • Cyclin D3
  • Cyclin E
  • Cyclins
  • HIV Envelope Protein gp120
  • HIV envelope protein gp120 (305-321)
  • Interleukin-2
  • Peptide Fragments
  • Recombinant Proteins
  • Cyclin D1
  • Protein Kinases
  • histone H1 kinase
  • Protein Serine-Threonine Kinases
  • CDC2-CDC28 Kinases
  • CDK2 protein, human
  • Cyclin-Dependent Kinase 2
  • Cyclin-Dependent Kinases